The management of cardiovascular diseases in patients with hemophilia

Seminars in Thrombosis and Hemostasis

Volumn 36, Issue 1, 2010, Pages 91-102

  Coppola, Antonio ^a   Tagliaferri, Annarita ^b   Franchini, Massimo ^b  

^a FEDERICO II UNIVERSITY HOSPITAL   (Italy)

^b UNIVERSITY HOSPITAL OF PARMA   (Italy)

Author keywords

Acute coronary syndromes; Anticoagulation; Antiplatelet agents; Bleeding risk; Cardiovascular disease; Comorbidities; Hemophilia; Percutaneous coronary intervention

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; FONDAPARINUX; HEPARIN; HIRULOG; LOW MOLECULAR WEIGHT HEPARIN; THIENOPYRIDINE DERIVATIVE; TICLOPIDINE; TRANEXAMIC ACID; WARFARIN;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; AGING; ANGINA PECTORIS; ANGIOPLASTY; AORTA VALVE REPLACEMENT; ATHEROSCLEROSIS; BARE METAL STENT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY STENT; DRUG ELUTING STENT; FOLLOW UP; HEART INFARCTION; HEART SURGERY; HEMOPHILIA; HEMOPHILIA A; HEMOPHILIA B; HUMAN; ISCHEMIC HEART DISEASE; LIFESTYLE MODIFICATION; LOW DRUG DOSE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVIEW; ST SEGMENT ELEVATION; STABLE ANGINA PECTORIS; TRANSLUMINAL CORONARY ANGIOPLASTY; UNSTABLE ANGINA PECTORIS;

ACUTE CORONARY SYNDROME; ANTICOAGULANTS; CARDIOVASCULAR DISEASES; CORONARY ARTERY BYPASS; FIBRINOLYTIC AGENTS; HEMOPHILIA A; HUMANS; MALE; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX;

EID: 77951051368     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0030-1248728     Document Type: Review

References (91)

1. Mannucci P M., Tuddenham E G. The hemophiliasfrom royal genes to gene therapy. N Engl J Med 2001 344 (23) 1773-1779
2. Mejia-Carvajal C, Czapek E E., Valentino L A. Life expectancy in hemophilia outcome. J Thromb Haemost 2006 4 (3) 507-509
3. Franchini M, Tagliaferri A, Mannucci P M. The management of hemophilia in elderly patients. Clin Interv Aging 2007 2 (3) 361-368
4. Stewart J W., Acheson J D. Atherosclerosis in a haemophiliac. Lancet 1957 272 1121-1122
5. Meili E O., Straub P W., Lichtlen P, Frick P G. Myocardial infarction in a haemophiliac. Demonstration of coronary sclerosis by selective angiography. Helv Med Acta 1968 34 (3) 239-243
6. Small M, Jack A S., Lowe G D., Mutch A F., Forbes C D., Prentice C R. Coronary artery disease in severe haemophilia. Br Heart J 1983 49 (6) 604-607 (Pubitemid 13106246)
7. Rosendaal F R., Varekamp I, Smit C et al. Mortality and causes of death in Dutch haemophiliacs, 197386. Br J Haematol 1989 71 (1) 71-76 (Pubitemid 19047700)
8. Triemstra M, Rosendaal F R., Smit C, Van der Ploeg H M., Brit E. Mortality in patients with hemophilia. Changes in a Dutch population from 1986 to 1992 and 1973 to 1986. Ann Intern Med 1995 123 (11) 823-827
9. Srmek A, Kriek M, Rosendaal F R. Decreased mortality of ischaemic heart disease among carriers of haemophilia. Lancet 2003 362 (9381) 351-354 (Pubitemid 36945057)
10. Plug I, Van Der Bom J G., Peters M et al. Mortality and causes of death in patients with hemophilia, 19922001: a prospective cohort study. J Thromb Haemost 2006 4 (3) 510-516
11. Koumbarelis E, Rosendaal F R., Gialeraki A et al. Epidemiology of haemophilia in Greece: an overview. Thromb Haemost 1994 72 (6) 808-813
12. Darby S C., Kan S W., Spooner R J. et al. Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV. Blood 2007 110 (3) 815-825
13. Soucie J M., Nuss R, Evatt B et al, The Hemophilia Surveillance System Project Investigators. Mortality among males with hemophilia: relations with source of medical care. Blood 2000 96 (2) 437-442 (Pubitemid 30463360)
14. Kulkarni R, Soucie J M., Evatt B L., Hemophilia Surveillance System Project Investigators. Prevalence and risk factors for heart disease among males with hemophilia. Am J Hematol 2005 79 (1) 36-42 (Pubitemid 40604789)
15. Tuinenburg A, Mauser-Bunschoten E P., Verhaar M C., Biesma D H., Schutgens R EG. Cardiovascular disease in patients with hemophilia. J Thromb Haemost 2009 7 (2) 247-254
16. Srmek A, Reiber J HC, Gerrits W BJ, Rosendaal F R. Decreased coagulability has no clinically relevant effect on atherogenesis: observations in individuals with a hereditary bleeding tendency. Circulation 2001 104 (7) 762-767
17. Sartori M T., Bilora F, Zanon E et al. Endothelial dysfunction in haemophilia patients. Haemophilia 2008 14 (5) 1055-1062
18. Franchini M. Thrombotic complications in patients with hereditary bleeding disorders. Thromb Haemost 2004 92 (2) 298-304 (Pubitemid 39172310)
19. Schimpf K L., Zeltsch C, Zeltsch P. Myocardial infarction complicating activated prothrombin complex concentrate substitution in a patient with hemophilia A. Lancet 1982 2 1043
20. Gruppo R A., Bove K E., Donaldson V H. Fatal myocardial necrosis associated with prothrombin-complex concentrate therapy in hemophilia A. N Engl J Med 1983 309 (4) 242-243
21. Sullivan D W., Purdy L J., Billingham M, Glader B E. Fatal myocardial infarction following therapy with prothrombin complex concentrates in a young man with hemophilia A. Pediatrics 1984 74 (2) 279-281 (Pubitemid 14054173)
22. Chavin S I., Siegel D M., Rocco T A. Jr, Olson J P. Acute myocardial infarction during treatment with an activated prothrombin complex concentrate in a patient with factor VIII deficiency and a factor VIII inhibitor. Am J Med 1988 85 (2) 245-249
23. Karayalcin G, Goldberg B, Cherrick I, Kurer C, Bierman F, Lanzkowsky P. Acute myocardial infarction complicating prothrombin complex concentrate therapy in an 8-year-old boy with hemophilia A and factor VIII inhibitor. Am J Pediatr Hematol Oncol 1993 15 (4) 416-419 (Pubitemid 23320141)
24. Khler M, Hellstern P, Lechler E, Uberfuhr P, Mller-Berghaus G. Thromboembolic complications associated with the use of prothrombin complex and factor IX concentrates. Thromb Haemost 1998 80 (3) 399-402 (Pubitemid 28438732)
25. Iannaccaro P, Santoro R, Sottilotta G, Papaleo G, Muleo G. Thrombosis in hemophiliacs with prothrombotic molecular defect. Clin Appl Thromb Hemost 2005 11 (3) 359-360 (Pubitemid 41022868)
26. Siboni S M., Mannucci P M., Gringeri A et al. Health status and quality of life of elderly persons with severe hemophilia born before the advent of modern replacement therapy. J Thromb Haemost 2009 7 (5) 780-786
27. Miesbach W, Alesci S, Krekeler S, Seifried E. Comorbidities and bleeding pattern in elderly haemophilia A patients. Haemophilia 2009 15 (4) 894-899
28. Girolami A, Ruzzon E, Fabris F et al. Myocardial infarction and other arterial occlusions in hemophilia A patients. A cardiological evaluation of all 42 cases reported in the literature. Acta Haematol 2006 116 120-125 (Pubitemid 44252768)
29. Girolami A, Randi M L., Ruzzon E, Zanon E, Girolami B. Myocardial infarction, other arterial thrombosis and invasive coronary procedures, in hemaophilia B: a critical evaluation of reported cases. J Thromb Thrombolysis 2005 20 (1) 43-46 (Pubitemid 41300621)
30. Aledort L M. Comparative thrombotic event incidence after infusion of recombinant factor VIIa versus factor VIII inhibitor bypass activity. J Thromb Haemost 2004 2 (10) 1700-1708
31. Negrier C, Goudemand J, Sultan Y, Bertrand M, Rothschild C, Lauroua P. Multicenter retrospective study on the utilization of FEIBA in France in patients with factor VIII and factor IX inhibitors. French FEIBA Study Group. Factor Eight Bypassing Activity. Thromb Haemost 1997 77 (6) 1113-1119
32. Ehrlich H J., Henzl M J., Gomperts E D. Safety of factor VIII inhibitor bypass activity (FEIBA): 10-year compilation of thrombotic adverse events. Haemophilia 2002 8 (2) 83-90
33. Franchini M, Zaffanello M, Veneri D. Recombinant factor VIIa. An update on its clinical use. Thromb Haemost 2005 93 (6) 1027-1035 (Pubitemid 40823504)
34. Roberts H R. Recombinant factor VIIa (NovoSeven) and the safety of treatment. Semin Hematol 2001 38 (4, suppl 12) 48-50 (Pubitemid 33130037)
35. Lippi G, Montagnana M, Salvagno G L., Guidi G C. Potential value for new diagnostic markers in the early recognition of acute coronary syndromes. CJEM 2006 8 (1) 27-31
36. Antithrombotic Trialists Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002 324 (7329) 71-86
37. Harrington R A., Becker R C., Cannon C P. et al, American College of Chest Physicians. Antithrombotic therapy for non-ST-segment elevation acute coronary syndromes: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008 133 (6, suppl) 670S-707S
38. Goodman S G., Menon V, Cannon C P., Steg G, Ohman E M., Harrington R A., American College of Chest Physicians. Acute ST-segment elevation myocardial infarction: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008 133 (6, suppl) 708S-775S (Pubitemid 351892976)
39. Moscucci M, Fox K A., Cannon C P. et al. Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE). Eur Heart J 2003 24 (20) 1815-1823 (Pubitemid 37280247)
40. Warkentin T E., Kelton J G. Temporal aspects of heparin-induced thrombocytopenia. N Engl J Med 2001 344 (17) 1286-1292
41. Merlini P A., Rossi M, Menozzi A et al. Thrombocytopenia caused by abciximab or tirofiban and its association with clinical outcome in patients undergoing coronary stenting. Circulation 2004 109 (18) 2203-2206
42. Mielke C H. Jr, Britten A F. Use of aspirin or acetaminophen in hemophilia. N Engl J Med 1970 282 (22) 1270
43. Quick A J. No aspirin for hemophiliacs. N Engl J Med 1971 284 (4) 218
44. MacKinlay N, Taper J, Renisson F, Rickard K. Cardiac surgery and catheterization in patients with haemophilia. Haemophilia 2000 6 (2) 84-88
45. Forman M B., Kopelman H A., Gleaton J H., Janco R L., Perry J M. Percutaneous transluminal coronary angioplasty in hemophilia. Am Heart J 1986 111 (1) 169-172
46. Helft G, Metzger J P., Samama M M., Rothschild C, Batisse J P., Vacheron A. Coronary stenting in a hemophilic patient. Thromb Haemost 1997 77 (5) 1044-1045
47. Peerlinck K, Vermylen J. Acute myocardial infarction following administration of recombinant activated factor VII (Novo Seven) in a patient with haemophilia A and inhibitor. Thromb Haemost 1999 82 (6) 1775-1776
48. Alsolaiman M M., Chang K, Arjomand H, Oza R, Costacurta G. Acute left anterior descending artery occlusion in a hemophiliac A patient during recombinant factor VIII infusion: treatment with coronary angioplasty. Catheter Cardiovasc Interv 2000 50 (4) 468-472
49. Au W Y., Jim M H., Lam C C. Unusual case of coronary artery disease in a patient with severe hemophilia B. Am J Hematol 2002 69 (2) 152-153
50. Bovenzi F, De Luca L, Signore N, Fusco F, de Luca I. Abciximab for the treatment of an acute thrombotic coronary occlusion during stent implantation in a patient with severe hemophilia B. Ital Heart J 2003 4 (10) 728-730
51. Kerkhoffs J L., Atsma D E., Oemrawsingh P V., Eikenboom J, Van der Meer F JM. Acute myocardial infarction during substitution with recombinant factor VIII concentrate in a patient with mild haemophilia A. Thromb Haemost 2004 92 (2) 425-426
52. Virtanen R, Kauppila M, Itl M. Percutaneous coronary intervention with stenting in a patient with haemophilia A and an acute myocardial infarction following a single dose of desmopressin. Thromb Haemost 2004 92 (5) 1154-1156
53. Arora U K., Dhir M, Cintron G, Strom J A. Successful multi-vessel percutaneous coronary intervention with bivalirudin in a patient with severe hemophilia A: a case report and review of literature. J Invasive Cardiol 2004 16 (6) 330-332
54. Krolick M A. Successful percutaneous coronary intervention in a patient with severe haemophilia A using bivalirudin as the sole procedural anticoagulant. Haemophilia 2005 11 (4) 415-417
55. Smolka G, Kulach A, Dabek J, Szulc A, Gasior Z. Percutaneous coronary intervention with stent implantation in haemophilic A patient with unstable angina. Haemophilia 2007 13 (4) 428-431
56. Ferrario C, Renders F, Cairoli A, Vuffray A, Spertini O, Angelillo-Scherrer A. Management of an acute coronary syndrome in a patient with severe haemophilia A. Haemophilia 2007 13 (6) 763-765
57. Quintero D, Biria M, Meyers D G. Percutaneous coronary intervention in a patient with acute ST-elevation myocardial infarction and hemophilia A. J Invasive Cardiol 2008 20 (5) 240-241
58. Coppola A, De Simone C, Di Capua M et al. Management of ischemic heart disease in hemophilic patients: new challenges from a case report and review of the literature [abstract]. Haemophilia 2008 14 (Suppl 2) 127
59. Rivolta G F., Di Perna C, Franchini M et al. Management of coronary artery disease in a severe haemophilia patient with high titre inhibitor and anaphylaxis. Haemophilia 2009 15 (5) 1161-1163
60. Schutgens R EG, Tuinenburg A, Roosendaal G, Guyomi S H., Mauser-Bunschoten E P. Treatment of ischaemic heart disease in haemophilia patients: an institutional guideline. Haemophilia 2009 15 (4) 952-958
61. Shaw S M., Fildes J E., Yonan N, Williams S G. Pleiotropic effects and cholesterol-lowering therapy. Cardiology 2009 112 (1) 4-12
62. Antman E M., Cohen M, Radley D et al. Assessment of the treatment effect of enoxaparin for unstable angina/non-Q-wave myocardial infarction. TIMI 11B-ESSENCE meta-analysis. Circulation 1999 100 (15) 1602-1608
63. Ferguson J J., Califf R M., Antman E M. et al,; SYNERGY Trial Investigators. Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial. JAMA 2004 292 (1) 45-54
64. Karthikeyan G, Mehta S R., Eikelboom J W. Fondaparinux in the treatment of acute coronary syndromes: evidence from OASIS 5 and 6. Expert Rev Cardiovasc Ther 2009 7 (3) 241-249
65. Bittl J A., Chaitman B R., Feit F, Kimball W, Topol E J. Bivalirudin versus heparin during coronary angioplasty for unstable or postinfarction angina: Final report reanalysis of the Bivalirudin Angioplasty Study. Am Heart J 2001 142 (6) 952-959
66. Maroo A, Lincoff A M. Bivalirudin in PCI: an overview of the REPLACE-2 trial. Semin Thromb Hemost 2004 30 (3) 329-336
67. Harker L A., Boissel J P., Pilgrim A J., Gent M. Comparative safety and tolerability of clopidogrel and aspirin: results from CAPRIE. CAPRIE Steering Committee and Investigators. Clopidogrel versus aspirin in patients at risk of ischaemic events. Drug Saf 1999 21 (4) 325-335
68. Cid A R., Zorio E, Haya S et al. Treatment in a haemophiliac A patient with paroxysmal atrial fibrillation and ischemic heart disease. Haemophilia 2007 13 (6) 760-762
69. Patrono C, Baigent C, Hirsh J, Roth G, American College of Chest Physicians. Antiplatelet drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008 133 (6, suppl) 199S-233S (Pubitemid 351894914)
70. Levine G N., Kern M J., Berger P B. et al. Management of patients undergoing percutaneous coronary revascularization. Ann Intern Med 2003 139 (2) 123-136
71. Iakovou I, Schmidt T, Bonizzoni E et al. Incidence, prediction and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005 293 (17) 2126-2130
72. Banerjee S, Varghese C, Samuel J et al. Comparison of the impact of short (<1 year) and long-term (>or=1 year) clopidogrel use following percutaneous coronary intervention on mortality. Am J Cardiol 2008 102 (9) 1159-1162
73. Agostoni P, Biondi-Zoccai G G., de Benedictis M L. et al. Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures: systematic overview and meta-analysis of randomized trials. J Am Coll Cardiol 2004 44 349-356 (Pubitemid 38950594)
74. Kinnaird T, Anderson R, Hill J, Thomas M. Bleeding during percutaneous intervention: tailoring the approach to minimise risk. Heart 2009 95 (1) 15-19
75. Cantor W J., Puley G, Natarajan M K. et al. Radial versus femoral access for emergent percutaneous coronary intervention with adjunct glycoprotein IIb/IIIa inhibition in acute myocardial infarctionthe RADIAL-AMI pilot randomized trial. Am Heart J 2005 150 (3) 543-549 (Pubitemid 41317627)
76. Koreny M, Riedmuller E, Nikfardjam M, Siostrzonek P, Mullner M. Arterial puncture closing devices compared with standard manual compression after cardiac catheterization: systematic review and meta-analysis. JAMA 2004 291 350-357 (Pubitemid 38101608)
77. Kwa A T., Rogers J H. Current update on glycoprotein IIb-IIIa and direct thrombin inhibition in percutaneous coronary intervention for non-ST elevation acute coronary syndromes: balancing bleeding risk and antiplatelet efficacy. J Interv Cardiol 2008 21 (2) 107-117
78. Lickfett L, Hagendorff A, Jung W, Pizzulli L, Brackmann H H., Lderitz B. Acute posterior wall infarct after factor VIII concentrate administration to a patient with severe hemophilia A [in German]. Dtsch Med Wochenschr 1998 123 (21) 658-662 (Pubitemid 28264535)
79. Tang M, Wierup P, Terp K, Ingerslev J, Srensen B. Cardiac surgery in patients with haemophilia. Haemophilia 2009 15 (1) 101-107
80. Legget P L., Doyle D, Smith W B. et al. Elective cardiac operation in a patient with severe haemophilia and acquired factor VIII antibodies. J Thorac Cardiovasc Surg 1984 87 (4) 556-560 (Pubitemid 14130478)
81. Mazzucco A, Stellin G, Cantele P, Boschello M, Traldi A, Gallucci V. Repair of ventricular septal defect and aortic regurgitation associated with severe hemophilia B. Ann Thorac Surg 1986 42 (1) 97-99 (Pubitemid 16088472)
82. Raish R J., Witte D L., Goldsmith J C. Successful cardiac surgery following plasmapheresis in a patient with hemophilia B. Transfusion 1985 25 (2) 128-130
83. Vander Woude J C., Milam J D., Walker W E., Houchin D P., Weiland A P., Cooley D A. Cardiovascular surgery in patients with congenital plasma coagulopathies. Ann Thorac Surg 1988 46 (3) 283-288
84. Palanzo D A., Sadr F S. Coronary artery bypass grafting in a patient with haemophilia B. Perfusion 1995 10 265-270
85. De Bels D, Demeere J L., Dugauquier J, Louis P, Van der Vorst E. Continuous infusion of factor VIIIc during heart surgery in a patient with haemophilia A. Eur J Anaesthesiol 2004 21 (12) 984-986 (Pubitemid 40288926)
86. Palareti G, Leali N, Coccheri S et al, Italian Study on Complications of Oral Anticoagulant Therapy. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Lancet 1996 348 (9025) 423-428
87. Kaminishi Y, Aizawa K, Saito T, Misawa Y, Madoiwa S, Sakata Y. Modified Bentall operation in a patient with hemophilia A. Jpn J Thorac Cardiovasc Surg 2003 51 (2) 68-70
88. Ghosh K, Shetty S. Anticoagulation in haemophilia patients with prosthetic valve replacement. Haemophilia 2004 10 (6) 743
89. Dargaud Y, Meunier S, Negrier C. Haemophilia and thrombophilia: an unexpected association! Haemophilia 2004 10 (4) 319-326
90. Franchini M, Lippi G. Together we care: new challenges for global haemophilia treatment centers. Indian J Med Res 2009 129 (4) 345-347
91. Mauser-Bunschoten E P., Fransen Van De Putte D E., Schutgens R EG. Co-morbidity in the ageing haemophilia patient: the down side of increased life expectancy. Haemophilia 2009 15 (4) 853-863